OBJECTIVES: Field-cancerized tissue can give rise to second primary tumours, causing therapeutic failure. Boron neutron capture therapy (BNCT) is based on biological targeting and would serve to treat undetectable foci of malignant transformation. The aim of this study was to optimize BNCT for the integral treatment for oral cancer, with particular emphasis on the inhibitory effect on tumour development originating in precancerous conditions, and radiotoxicity of different BNCT protocols in a hamster cheek pouch oral precancer model. MATERIALS AND METHODS: Groups of cancerized hamsters were locally exposed to single or double (2 or 4 weeks apart) applications of BNCT at different dose levels, mediated by the boron compounds boronophenylalanine (BPA) or BPA and decahydrodecaborate (GB-10) administered jointly. Cancerized, sham-irradiated hamsters served as controls. Clinical status, tumour development from field-cancerized tissue and mucositis were followed for 8 months. RESULTS: A double application (4 weeks apart) of BNCT mediated by GB-10+ BPA at a total dose of 10 Gy in two 5-Gy doses rendered the best therapeutic advantage (63-100% inhibition of tumour development from field-cancerized tissue), minimizing dose-limiting mucositis. CONCLUSION: BNCT can be optimized for the integral treatment for head and neck cancer, considering the implications for field-cancerized tissue.
OBJECTIVES: Field-cancerized tissue can give rise to second primary tumours, causing therapeutic failure. Boron neutron capture therapy (BNCT) is based on biological targeting and would serve to treat undetectable foci of malignant transformation. The aim of this study was to optimize BNCT for the integral treatment for oral cancer, with particular emphasis on the inhibitory effect on tumour development originating in precancerous conditions, and radiotoxicity of different BNCT protocols in a hamster cheek pouch oral precancer model. MATERIALS AND METHODS: Groups of cancerized hamsters were locally exposed to single or double (2 or 4 weeks apart) applications of BNCT at different dose levels, mediated by the boron compounds boronophenylalanine (BPA) or BPA and decahydrodecaborate (GB-10) administered jointly. Cancerized, sham-irradiated hamsters served as controls. Clinical status, tumour development from field-cancerized tissue and mucositis were followed for 8 months. RESULTS: A double application (4 weeks apart) of BNCT mediated by GB-10+ BPA at a total dose of 10 Gy in two 5-Gy doses rendered the best therapeutic advantage (63-100% inhibition of tumour development from field-cancerized tissue), minimizing dose-limiting mucositis. CONCLUSION: BNCT can be optimized for the integral treatment for head and neck cancer, considering the implications for field-cancerized tissue.
Authors: Verónica A Trivillin; David B Abramson; Gaston E Bumaguin; Leandro J Bruno; Marcela A Garabalino; Andrea Monti Hughes; Elisa M Heber; Sara Feldman; Amanda E Schwint Journal: Radiat Environ Biophys Date: 2014-08-26 Impact factor: 1.925
Authors: Elisa M Heber; M Frederick Hawthorne; Peter J Kueffer; Marcela A Garabalino; Silvia I Thorp; Emiliano C C Pozzi; Andrea Monti Hughes; Charles A Maitz; Satish S Jalisatgi; David W Nigg; Paula Curotto; Verónica A Trivillin; Amanda E Schwint Journal: Proc Natl Acad Sci U S A Date: 2014-10-27 Impact factor: 11.205
Authors: Marcela A Garabalino; Nahuel Olaiz; Agustina Portu; Gisela Saint Martin; Silvia I Thorp; Emiliano C C Pozzi; Paula Curotto; María E Itoiz; Andrea Monti Hughes; Lucas L Colombo; David W Nigg; Verónica A Trivillin; Guillermo Marshall; Amanda E Schwint Journal: Radiat Environ Biophys Date: 2019-05-23 Impact factor: 1.925
Authors: Andrea Monti Hughes; Juan Longhino; Esteban Boggio; Vanina A Medina; Diego J Martinel Lamas; Marcela A Garabalino; Elisa M Heber; Emiliano C C Pozzi; María E Itoiz; Romina F Aromando; David W Nigg; Verónica A Trivillin; Amanda E Schwint Journal: Radiat Environ Biophys Date: 2017-09-04 Impact factor: 1.925
Authors: Verónica A Trivillin; Emiliano C C Pozzi; Lucas L Colombo; Silvia I Thorp; Marcela A Garabalino; Andrea Monti Hughes; Sara J González; Rubén O Farías; Paula Curotto; Gustavo A Santa Cruz; Daniel G Carando; Amanda E Schwint Journal: Radiat Environ Biophys Date: 2017-08-08 Impact factor: 1.925
Authors: Verónica A Trivillin; Leandro J Bruno; David A Gatti; Mariela Stur; Marcela A Garabalino; Andrea Monti Hughes; Jorge Castillo; Emiliano C C Pozzi; Luis Wentzeis; Hugo Scolari; Amanda E Schwint; Sara Feldman Journal: Radiat Environ Biophys Date: 2016-08-27 Impact factor: 1.925
Authors: Verónica A Trivillin; Yanina V Langle; Mónica A Palmieri; Emiliano C C Pozzi; Silvia I Thorp; Debora N Benitez Frydryk; Marcela A Garabalino; Andrea Monti Hughes; Paula M Curotto; Lucas L Colombo; Iara S Santa Cruz; Paula S Ramos; María E Itoiz; Claudia Argüelles; Ana M Eiján; Amanda E Schwint Journal: Br J Radiol Date: 2021-09-14 Impact factor: 3.039
Authors: Andrea Monti Hughes; Jessica A Goldfinger; Mónica A Palmieri; Paula Ramos; Iara S Santa Cruz; Luciana De Leo; Marcela A Garabalino; Silvia I Thorp; Paula Curotto; Emiliano C C Pozzi; Kazuki Kawai; Shinichi Sato; María E Itoiz; Verónica A Trivillin; Juan S Guidobono; Hiroyuki Nakamura; Amanda E Schwint Journal: Life (Basel) Date: 2022-07-20